Newsroom

Newsroom

Stay informed with the latest press releases, industry updates, and insights from Innovative Medicines Canada.

Filter by

Press releases

Federal task force report marks important step for Canada’s life sciences sector

Innovative Medicines Canada (IMC) acknowledges today’s publication of the Pharmaceutical and Life Sciences Sector Task Force report by the ministers of health and industry, featuring recommendations to improve patient access to life-saving medications. Turning these recommendations into urgent action will be critical given recent global drug policy shifts triggered by U.S. most-favoured nation pricing, which are already influencing where innovative medicines are launched.

In the news

Canada’s wait for new medicines is long — and about to get longer

There’s a quiet crisis unfolding behind closed doors. Canadians have the longest wait times in the G7 for public access to new and innovative medicines — the patented, breakthrough kind that treat cancer, autoimmune disorders, and rare and infectious diseases. In addition, only 18 per cent of new drugs launched globally are available through Canadian public drug plans. Now, global drug policy changes, triggered by a new U.S. policy, threaten to widen this gap further. 
1 2 3

resources

Discover. Learn.
Understand.

Stay informed with timely, relevant content on key issues shaping our industry.

Learn more